Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Synapse. 2010 Apr;64(4):280–288. doi: 10.1002/syn.20723

Figure 2.

Figure 2

Representative “shift experiments” in membranes prepared from HERK-treated cells with an agonist (dynorphin A(1-13), Panel A) and an inverse agonist (CTAP, Panel B). Each value is the mean±SD (n=4 for Panel A, n=3 for Panel B). The Ke values are reported in Table 3.